CASP3 and central nervous system cancer: Caspase-3 activation has been widely recognized as a factor in the therapy of various cancers including glioma, yet Caspase-3 activation in dying glioma cells has been noted to create an unfavorable environment for angiogenesis after irradiation [31, 32], suggesting the need of more in-depth studies.